株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

未分化甲状腺癌:世界の治験動向

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 328410
出版日 ページ情報 英文 75 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.34円で換算しております。
Back to Top
未分化甲状腺癌:世界の治験動向 Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2017
出版日: 2017年03月31日 ページ情報: 英文 75 Pages
概要

当レポートでは、未分化甲状腺癌の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域
    • 主要国における治験件数; 中南米

G7諸国における治験件数:未分化甲状腺癌治験件数の腫瘍治験件数に対する比率

フェーズ(相)別治験件数:G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数:未分化甲状腺癌治験件数の腫瘍治験件数に対する比率

フェーズ(相)別治験件数:E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別治験件数

有望なスポンサー

治験主要参加企業 - 未分化甲状腺癌治療薬

有望な薬剤

治験プロファイルの基本情報

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Anaplastic Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Anaplastic Thyroid Cancer Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Clinical Trial Profile Snapshots 33

Appendix 72

  • Abbreviations 72
  • Definitions 72
  • Research Methodology 73
  • Secondary Research 73
  • About GlobalData 74
  • Contact Us 74
  • Disclaimer 74
  • Source 75

List of Tables

  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures

  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Anaplastic Thyroid Cancer Therapeutics,
Back to Top